D-0184-2023 Class I Terminated

Recalled by Pfizer Inc. — New York, NY

FDA drug recall D-0184-2023 was initiated by Pfizer Inc. on Dec 22, 2022 and is designated Class I. Reason for recall: Presence of Particulate Matter: Glass particulate matter detected in injectable. The recall status is terminated (terminated Aug 7, 2024). Affected quantity: 89,700 vials.

Recall details

Product Type
Drugs
Report Date
Feb 1, 2023
Initiation Date
Dec 22, 2022
Termination Date
Aug 7, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
89,700 vials

Product description

Vancomycin Hydrochloride for Injection, USP, 1.5 g/vial, Sterile powder, Single-dose Fliptop Vial, 10 vials per carton, Rx only, Distributed by: Hospira, Inc., Lake Forest, IL 60045. NDC Vial 0409-3515-11; NDC Carton 0409-3515-01

Reason for recall

Presence of Particulate Matter: Glass particulate matter detected in injectable.

Distribution pattern

USA nationwide and Puerto Rico

Code information

Lot: 33045BA, EXP 1SEP2023

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0184-2023
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Pfizer Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for D-0184-2023. Report a data issue: hello@regdatalab.com.